Laryngeal muscles are spared in the dystrophin deficient mdx mouse

Journal of Speech, Language, and Hearing Research

Volumn 51, Issue 3, 2008, Pages 586-595

  Thomas, Lisa B ^b   Joseph, Gayle L ^a   Adkins, Tracey D ^a   Andrade, Francisco H ^a   Stemple, Joseph C ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b MARSHALL UNIVERSITY   (United States)

Author keywords

Laryngeal; Muscles; Muscular dystrophy; Posterior cricoarytenoid; Thyroarytenoid

Indexed keywords

DYSTROPHIN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHIN DEFICIENCY; INFLAMMATION; LARYNX CARTILAGE; LARYNX MUSCLE; MALE; MEMBRANE DAMAGE; MOUSE; MUSCLE REGENERATION; NECROSIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; SKELETAL MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; ARYTENOID CARTILAGE; CRICOID CARTILAGE; DYSTROPHIN; IMMUNOHISTOCHEMISTRY; LARYNGEAL MUSCLES; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES;

EID: 46949101213     PISSN: 10924388     EISSN: None     Source Type: Journal    
DOI: 10.1044/1092-4388(2008/042)     Document Type: Article

References (63)

1. Andrade, F. H., Porter, J. D., & Kaminski, H. J. (2000). Eye muscle sparing by the muscular dystrophies: Lessons to be learned? Microscopy Research and Technique, 48, 192-203.
2. Banker, B. Q., & Engel, A. G. (1994). Basic reactions of muscle. In A. G. Engle & C. Franzini-Armstrong (Eds.), Myology (2nd ed., Vol. 1, pp. 832-888). New York: McGraw Hill.
3. Beck, J., Weinberg, J., Hamnegard, C. H., Spahija, J., Olofson, J., Grimby, G., et al. (2006). Diaphragmatic function in advanced Duchenne muscular dystrophy. Neuromuscular Disorders, 16, 161-167.
4. Bendiksen, F. S., Dahl, H. A., & Teig, E. (1981). Innervation pattern of different types of muscle fibers in the human thyroarytenoid muscle. Acta Otolaryngologica, 91, 391-397.
5. Blake, D. J., Weir, A., Newey, S. E., & Davies, K. E. (2002). Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiology Reviews, 82, 291-329.
6. Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J. (1984). X chromosome-linked muscular dystrophy (mdx) in the mouse. Proceedings of the National Academy of Sciences, USA, 81, 1189-1192.
7. Caress, J. B., Kothari, M. J., Bauer, S. B., & Shefner, J. M. (1996). Urinary dysfunction in Duchenne muscular dystrophy. Muscle and Nerve, 19, 819-822.
8. Cohn, R. D., & Campbell, K. P. (2000). Molecular basis of muscular dystrophies. Muscle and Nerve, 23, 1456-1471.
9. Davies, K. E., & Nowak, K. J. (2006). Molecular mechanisms of muscular dystrophies: Old and new players. Nature Reviews, 7, 762-773.
10. Deem, J. F., & Miller, L. (2000). Manual of voice therapy. Austin, TX: Pro-Ed.
11. Dowling, P., Culligan, K., & Ohlendieck, K. (2002). Distal mdx muscle groups exhibiting up-regulation of utrophin and rescue of dystrophin-associated glycoproteins exemplify a protected phenotype in muscular dystrophy. Naturwissenschaften, 89, 75-78.
12. Engel, A. G., & Banker, B. Q. (1994). Ultrastructural changes in diseased muscle. In A. G. Engel & C. Franzini-Armstrong (Eds.), Myology (2nd ed., Vol. 1, pp. 889-1017). New York: McGraw-Hill.
13. Fischer, M. D., Budak, M. T., Bakay, M., Gorospe, J. R., Kjellgren, D., Pedrosa-Domellof, F., et al. (2005). Definition of the unique human extraocular muscle allotype by expression profiling. Physiological Genomics, 22, 283-291.
14. Froeschels, E. (1944). Experience of a bloodless treatment for recurrens-paralysis. Journal of Laryngology, 59, 347-358.
15. Froeschels, E., Kastein, S., & Weiss, D. A. (1955). A method of therapy for paralytic conditions of the mechanisms of phonation respiration and glutination. Journal of Speech and Hearing Disorders, 20, 365-370.
16. Gillis, J. M. (1999). Understanding dystrophinopathies: An inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse. Journal of Muscle Research and Cell Motility, 20, 605-625.
17. Goding, G. S., Al-Sharif, K. I., & McLoon, L. K. (2005). Myonuclear addition to uninjured laryngeal myofibers in adult rabbits. Annals of Otology, Rhinology, & Laryngology, 114, 552-557.
18. Hicks, D. M., & Bless, D. M. (2000). Principles of treatment. In W. S. Brown, B. P. Vinson, & M. A. Crary (Eds.), Organic voice disorders: Assessment and treatment (pp. 172-191). San Diego, CA: Singular.
19. Hoffman, E. P., Brown, R. H., Jr., & Kunkel, L. M. (1987). Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919-928.
20. Horobin, R. W. (1988). Understanding histochemistry: Selection, evaluation, and design of biological stains. New York: Ellis Horwood Limited.
21. Hyodo, M., Kawakita, S., & Desaki, J. (2001). Scanning electron microscopic study of the muscle fiber ends at the myotendinous junction in the posterior cricoarytenoid and cricothyroid muscles in rats. Acta Otolaryngologica, 121, 953-956.
22. Kaminski, H. J., Al-Hakim, M., Leigh, J., Katirji, M. B., & Ruff, R. L. (1992). Extraocular muscles are spared in advanced Duchenne dystrophy. Annals of Neurology, 32, 586-588.
23. Kaplan, L. C., Osborne, P., & Elias, E. (1986). The diagnosis of muscular dystrophy in patients referred for language delay. Journal of Child Psychology and Psychiatry, 27, 545-549.
24. Karpati, G., & Carpenter, S. (1986). Small-caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression. American Journal of Medical Genetics, 25, 653-658.
25. Karpati, G., Carpenter, S., & Prescott, S. (1988). Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle and Nerve, 11, 795-803.
26. Khurana, T. S., Prendergast, R. A., Alameddine, H. S., Tome, F. M. S., Fardeau, M., Arahata, K., et al. (1995). Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: Role for calcium homeostasis in extra-ocular muscle sparing. Journal of Experimental Medicine, 182, 467-475.
27. Khurana, T. S., Watkins, S. C., Chafey, P., Chelly, J., Tome, F. M., Fardeau, M., et al. (1991). Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscular Disorders, 1, 185-194.
28. Kleopa, K. A., Drousiotou, A., Mavrikiou, E., Ormiston, A., & Kyriakides, T. (2006). Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy. Human Molecular Genetics, 15, 1623-1628.
29. Konig, W. F., & von Leden, H. (1961). The peripheral nervous system of the human larynx. Archives of Otolaryngology, 74, 45-55.
30. Lacomis, D., Kupsky, W. J., Kuban, K. K., & Specht, L. A. (1991). Childhood onset oculopharyngeal muscular dystrophy. Pediatrics Neurology, 7, 382-384.
31. Lapidos, K. A., Kakkar, R., & McNally, E. M. (2004). The dystrophin glycoprotein complex: Signaling strength and integrity for the sarcolemma. Circulation Research, 94, 1023-1031.
32. Lucas, C., Rughani, A., & Hoh, J. F. (1995). Expression of extraocular myosin heavy chain in rabbit laryngeal muscle. Journal of Muscle Research and Cell Motility, 16, 368-378.
33. Marques, M. J., Ferretti, R., Vomero, V. U., Minatel, E., & Neto, H. S. (2007). Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy. Muscle and Nerve, 35, 349-353.
34. Matsuda, R., Nishikawa, A., & Tanaka, H. (1995). Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: Evidence of apoptosis in dystrophin-deficient muscle. Journal of Biochemistry, 118, 959-964.
35. McLoon, L. K., Rowe, J., Wirtschafter, J., & McCormick, K. M. (2004). Continuous myofiber remodeling in uninjured extraocular myofibers: Myonuclear turnover and evidence for apoptosis. Muscle and Nerve, 29, 707-715.
36. McMullen, C. A., & Andrade, F. H. (2006). Contractile dysfunction and altered metabolic profile of the aging rat thyroarytenoid muscle. Journal of Applied Physiology, 100, 602-608.
37. Menache, C. C., & Darras, B. T. (2001). Myopathies: Inherited myopathies. In B. Katirji, H. Kaminski, D. C. Preston, R. L. Russ, & B. E. Shapiro (Eds.), Neuromuscular disorders in clinical practice (pp. 1028-1048). Boston: Butterworth-Heinemann.
38. Merati, A. L., Bodine, S. C., Bennett, T., Jung, H. H., Furuta, H., & Ryan, A. F. (1996). Identification of a novel myosin heavy chain gene expressed in the rat larynx. Biochimica et Biophysica Acta, 1306, 153-159.
39. Meyerson, M. D., Lewis, E., & Ill, K. (1984). Facioscapulohumeral muscular dystrophy and accompanying hearing loss. Archives of Otolaryngology, 110, 261-266.
40. Mizuno, Y., Nonaka, I., Hirai, S., & Ozawa, E. (1993). Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects. Journal of the Neurological Sciences, 199, 43-52.
41. Mullendore, J. M., & Stoudt, R. J., Jr. (1961). Speech patterns of muscular dystrophic individuals. Journal of Speech and Hearing Disorders, 26, 252-257.
42. Perie, S., Agbulut, O., St. Guily, J. L., & Butler-Browne, G. S. (2000). Myosin heavy chain expression in human laryngeal muscle fibers: A biochemical study. Annals of Otology, Rhinology, and Laryngology, 109, 216-220.
43. Perie, S., St. Guily, J. L., Callard, P., & Sebille, A. (1997). Innervation of adult human laryngeal muscle fibers. Journal of the Neurological Sciences, 149, 81-86.
44. Porter, J. D., Khanna, S., Kaminski, H. J., Rao, J. S., Merriam, A. P., Richmonds, C. R., et al. (2002). A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Human Molecular Genetics, 11, 263-272.
45. Porter, J. D., Merriam, A. P., Khanna, S., Andrade, F. H., Richmonds, C. R., Leahy, P., et al. (2003). Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice. The FASEB Journal, 17, 893-895.
46. Porter, J. D., Rafael, J. A., Ragusa, R. J., Brueckner, J. K., Trickett, J. I., & Davies, K. E. (1998). The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin. Journal of Cell Science, 111, 1801-1811.
47. Rando, T. A. (2001). The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle and Nerve, 24, 1575-1594.
48. Rhee, H. S., Lucas, C. A., & Hoh, J. F. (2004). Fiber types in rat laryngeal muscles and their transformations after denervation and reinnervation. Journal of Histochemistry and Cytochemistry, 52, 581-590.
49. Rossi, G., & Cortesina, G. (1965, May 8). Multi-motor end-plate muscle fibers in the human vocalis muscle. Nature, 206, 629-630.
50. Sanders, L. J., & Perlstein, M. A. (1965). Speech mechanism in pseudohypertrophic muscular dystrophy. American Journal of Diseases of Children, 109, 538-543.
51. Sciote, J. J., Morris, T. J., Brandon, C. A., Horton, M. J., & Rosen, C. (2002). Unloaded shortening velocity and myosin heavy chain variations in human laryngeal muscle fibers. Annals of Otology, Rhinology, and Laryngology, 111, 120-127.
52. Sheehan, D. C., & Hrapchack, B. B. (1980). Theory and practice of histotechnology. Columbus, OH: Batelle Press.
53. Shim, J. Y., & Kim, T. S. (2003). Relationship between utrophin and regenerating muscle fibers in Duchenne muscular dystrophy. Yonsei Medical Journal, 44, 15-23.
54. Shinners, M. J., Goding, G. S., & McLoon, L. K. (2006). Effect of recurrent laryngeal nerve section on the laryngeal muscles of adult rabbits. Otolaryngology - Head and Neck Surgery, 134, 413-418.
55. Shiotani, A., & Flint, P. W. (1998). Expression of extraocular-superfast-myosin heavy chain in rat laryngeal muscles. NeuroReport, 9, 3639-3642.
56. Shiotani, A., Westra, W. H., & Flint, P. W. (1999). Myosin heavy chain composition in human laryngeal muscles. Laryngoscope, 109, 1521-1524.
57. Speer, M. C., Gilchrist, J. M., Chutkow, J. G., McMichael, R., Westbrook, C. A., Stajich, J. M., et al. (1995). Evidence for locus heterogeneity in autosomal dominant limb-girdle muscular dystrophy. American Journal of Human Genetics, 57, 1371-1376.
58. Stedman, H. H., Sweeney, H. L., Shrager, J. B., Maguire, H. C., Panettieri, R. A., Petrof, B., et al. (1991, August 8). The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature, 352, 536-539.
59. Stemple, J. C. (1993). Voice therapy: Clinical studies. St. Louis, MO: Mosby.
60. Stemple, J. C., Lee, L., D'Amico, B., & Pickup, B. (1994). Efficacy of vocal function exercises as a method of improving voice production. Journal of Voice, 8, 271-289.
61. Straub, V., Rafael, J. A., Chamberlain, J. S., & Campbell, K. P. (1997). Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. Journal of Cell Biology, 139, 375-385.
62. Tinsley, J., Deconinck, N., Fisher, R., Kahn, D., Phelps, S., Gillis, J., et al. (1998). Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nature Medicine, 4, 1441-1444.
63. Young, E. C., & Durant-Jones, L. (1997). Gradual onset of dysphagia: A study of patients with oculopharyngeal muscular dystrophy. Dysphagia, 12, 196-201.